McDonald et al. (32) reported that IL-6, Tim-3, Stimulation-2 (ST2), and sTNFR1 levels in plasma could predict the development of non-relapse mortality and more severe GVHD in patients with gastrointestinal GVHD. Here, HAVCR2 is linked to graft versus host disease.